Erhardt; Paul W.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Erhardt; Paul W..The latest application filed is for "proxisome proliferator activated receptor (ppar) compounds and methods of using the same".

Company Profile

7.25.25

Erhardt; Paul W. - Toledo OH
Erhardt; Paul W. - Sylvania OH US
Erhardt, Paul W - Sylvania OH
Erhardt; Paul W. - Long Valley NJ
Erhardt; Paul W. - Mundelein IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Materials and methods useful to induce cancer cell death via methuosis or autophagy or a combination thereof Grant 11,406,626 - Tiwari , et al. August 9, 2	2022-08-09
Proxisome Proliferator Activated Receptor (ppar) Compounds And Methods Of Using The Same App 20210163431 - Heck; Bruce E. ; et al.	2021-06-03
Proxisome proliferator activated receptor (PPAR) compounds and methods of using the same Grant 10,941,125 - Heck , et al. March 9, 2	2021-03-09
Vacuole-inducing Compounds, Methods Of Making And Using The Same App 20210038586 - Maltese; William A. ; et al.	2021-02-11
Analogs of Proxisome Proliferator Activated Receptor (PPAR) Agonists and Methods of Using the Same App 20210038571 - Heck; Bruce E. ; et al.	2021-02-11
Materials And Methods Useful To Induce Cancer Cell Death Via Methuosis Or Autophagy Or A Combination Thereof App 20200297709 - Tiwari; Amit K. ; et al.	2020-09-24
Analogs of proxisome proliferator activated receptor (PPAR) agonists and methods of using the same Grant 10,776,461 - Heck , et al. Sept	2020-09-15
Vacuole-inducing Compounds, Methods Of Making And Using The Same App 20200000789 - Maltese; William A. ; et al.	2020-01-02
Proxisome Proliferator Activated Receptor (PPAR) Compounds and Methods of Using the Same App 20190330166 - Heck; Bruce E. ; et al.	2019-10-31
Analogs of Proxisome Proliferator Activated Receptor (PPAR) Agonists and Methods of Using the Same App 20190147147 - Heck; Bruce E. ; et al.	2019-05-16
Analogs of proxisome proliferator activated receptor (PPAR) agonists and methods of using the same Grant 10,181,018 - Heck , et al. Ja	2019-01-15
Analogs Of Proxisome Proliferator Activated Receptor (ppar) Agonists And Methods Of Using The Same App 20180012002 - Heck; Bruce E. ; et al.	2018-01-11
Inhibitors of ERCC1-XPF and methods of using the same Grant 9,821,008 - Patrick , et al. November 21, 2	2017-11-21
Target for Anthelmintic Development, and Anthelmintics Utilizing the Same App 20170311599 - Komuniecki; Richard ; et al.	2017-11-02
Inhibitors Of Ercc1-xpf And Methods Of Using The Same App 20160296556 - PATRICK; Stephan M. ; et al.	2016-10-13
Materials and methods useful to induce vacuolization, cell death, or a combination thereof Grant 9,061,994 - Maltese , et al. June 23, 2	2015-06-23
Materials And Methods Useful To Induce Vacuolization, Cell Death, Or A Combination Thereof App 20150152049 - Maltese; William A. ; et al.	2015-06-04
Materials and methods useful to induce cell death via methuosis Grant 9,028,796 - Maltese , et al. May 12, 2	2015-05-12
Materials and Methods Useful to Induce Vacuolization, Cell Death, or a Combination Thereof Grant 9,023,871 - Maltese , et al. May 5, 2	2015-05-05
Materials and Methods Useful to Induce Cell Death via Methuosis App 20140322128 - Maltese; William A. ; et al.	2014-10-30
Materials and Methods Useful to Induce Vacuolization, Cell Death, or a Combination Thereof App 20140213615 - Maltese; William A. ; et al.	2014-07-31
Methods for synthesizing glycinols, glyceollins I and II, compositions of selected intermediates, and therapeutic uses thereof Grant 8,563,599 - Erhardt , et al. October 22, 2	2013-10-22
Methods for synthesizing glycinols, glyceollins I and II and isoflavenes and chromanes using a Wittig reaction, and compositions made therewith Grant 8,507,549 - Erhardt , et al. August 13, 2	2013-08-13
Methods for Synthesizing Glycinols, Glyceollins I and II and Isoflavenes and Chromanes Using A Wittig Reaction, and Compositions Made Therewith App 20120115942 - Erhardt; Paul W. ; et al.	2012-05-10
Methods For Synthesizing Glycinols, Glyceollins I And Ii, Compositions Of Selected Intermediates, And Therapeutic Uses Thereof App 20110144195 - Erhardt; Paul W. ; et al.	2011-06-16
Aralkyl ester soft drugs App 20070135505 - Erhardt; Paul W.	2007-06-14
Aralkyl ester soft drugs Grant 7,164,027 - Erhardt January 16, 2	2007-01-16
Method and compositions for temporarily incapacitating subjects App 20060223784 - Erhardt; Paul W.	2006-10-05
Method and compositions for temporarily incapacitating subjects Grant 7,049,326 - Erhardt May 23, 2	2006-05-23
Paclitaxel hybrid derivatives App 20060052312 - Erhardt; Paul W. ; et al.	2006-03-09
Method for the selective removal of acyl-functionality attached to the 2'-hydroxy-group of paclitaxel-related derivatives Grant 6,846,937 - Erhardt , et al. January 25, 2	2005-01-25
Aralkyl ester soft drugs App 20040224924 - Erhardt, Paul W.	2004-11-11
Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs App 20040224925 - Erhardt, Paul W. ; et al.	2004-11-11
Method for the selective removal of acyl-functionality attached to the 2' hydroxy-group of paclitaxel-related derivatives App 20040181079 - Erhardt, Paul W ; et al.	2004-09-16
Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs Grant 6,756,047 - Erhardt , et al. June 29, 2	2004-06-29
Aralkyl ester soft drugs Grant 6,750,238 - Erhardt June 15, 2	2004-06-15
Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs App 20030130236 - Erhardt, Paul W. ; et al.	2003-07-10
Method and compositions for temporarily incapacitating subjects App 20030095992 - Erhardt, Paul W.	2003-05-22
Aralkyl ester soft drugs App 20030096858 - Erhardt, Paul W.	2003-05-22
Methods for producing two-substituted glycerols having various levels of protection Grant 6,255,540 - Erhardt , et al. July 3, 2	2001-07-03
Inhibitors of the conversion of big endothelin to endothelin Grant 5,504,070 - Bihovsky , et al. April 2, 1	1996-04-02
Prodrug derivatives of the cardiotonic agent 4-ethyl-1,3-dihydro-5-(4-(2-methyl-1H-imidazol-1-yl)benzoyl)-2H-imidazol -2-one, composition containing them, and method of using them to treat cardiac failure Grant 4,743,612 - Erhardt , et al. May 10, 1	1988-05-10
Compounds for treatment or prophylaxis of cardiac disorders Grant 4,604,481 - Kam , et al. August 5, 1	1986-08-05
Method for treatment or prophylaxis of cardiac disorders Grant 4,593,119 - Erhardt , et al. June 3, 1	1986-06-03
Ethylenediamine derivatives of aryloxypropanolamine aryl esters having various medicinal properties Grant 4,556,668 - Erhardt , et al. December 3, 1	1985-12-03
Cardiotonic 1,3-dihydro-4-[[(imidazol-1-yl)aryl]carbonyl]imidazol-2-ones Grant 4,556,665 - Erhardt , et al. December 3, 1	1985-12-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.